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Abstract
Animal and human studies have demonstrated that early pain experiences can produce alterations in the nociceptive
systems later in life including increased sensitivity to mechanical, thermal, and chemical stimuli. However, less is known
about the impact of neonatal immune challenge on future responses to noxious stimuli and the reactivity of neural
substrates involved in analgesia. Here we demonstrate that rats exposed to Lipopolysaccharide (LPS; 0.05 mg/kg IP,
Salmonella enteritidis) during postnatal day (PND) 3 and 5 displayed enhanced formalin-induced flinching but not licking
following formalin injection at PND 22. This LPS-induced hyperalgesia was accompanied by distinct recruitment of supra-
spinal regions involved in analgesia as indicated by significantly attenuated Fos-protein induction in the rostral dorsal
periaqueductal grey (DPAG) as well as rostral and caudal axes of the ventrolateral PAG (VLPAG). Formalin injections were
associated with increased Fos-protein labelling in lateral habenula (LHb) as compared to medial habenula (MHb), however
the intensity of this labelling did not differ as a result of neonatal immune challenge. These data highlight the importance of
neonatal immune priming in programming inflammatory pain sensitivity later in development and highlight the PAG as a
possible mediator of this process.
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Introduction
Neonatal pain experiences such as hindpaw incision or
inflammation are known to produce developmentally regulated
changes in the nociceptive pathways, and subsequently exagger-
ated responses to future noxious and non-noxious stimuli [1–3].
Both clinical and animal studies have shown that changes in
endogenous pain modulation can also occur as a consequence of
neonatal inflammatory pain [4–6]. Although the effects of
neonatal pain experiences on processing of pain later in life are
well documented, the impact of neonatal exposure to mild stimuli,
such as lipopolysaccharide (LPS), on subsequent inflammatory
pain responses is less well understood.
Exposure to LPS during perinatal life is an established model of
early life immune stress [7–10]. Our laboratory and others have
demonstrated that neonatal LPS exposure alters immune and
neuroendocrine function later in life [11–13]. Interestingly, we
recently demonstrated that neonatal LPS exposure can also affect
inflammatory pain responses, as indicated by enhanced suscepti-
bility to formalin-induced flinching in LPS-challenged preadoles-
cent rats [10]. We have also shown that LPS-induced behavioural
hyperalgesia observed at postnatal day (PND) 22 is accompanied
by increased plasma corticosterone responses and changes in the
intrinsic properties of spinal dorsal horn neurons [10].
The inhibitory descending pathways travelling from the
periaqueductal grey (PAG) via the dorsolateral funiculus (DLF)
to the rostroventromedial medulla (RVM) and the spinal dorsal
horn constitute a major anatomical circuit for the descending
modulation of pain [14,15]. This system becomes fully mature by
the third week of development [16]. The PAG serves key functions
in this inhibitory descending pathway including promoting
analgesia [17–20]. For instance, formalin injection into the
hindpaw of infant and adult rats is associated with Fos expression
in the PAG [21,22]. Further, PAG stimulation or an injection of
morphine prior to formalin injection attenuated formalin-induced
nociception [23]. Anatomically, the PAG is organized into
longitudinal columns, namely dorsal PAG (DPAG), lateral PAG
(LPAG) and ventrolateral PAG (VLPAG) [24]. Whereas electrical,
opiate, or amino acid stimulation of the ventral PAG elicits opioid-
dependent analgesia, electrical or glutamatergic stimulation of the
DPAG or LPAG induces analgesia that is not blocked by opioid
antagonist (e.g. naloxone) [24–27]. One structure that provides
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significant input onto the PAG to mediate antinociception is the
habenula, particularly its lateral subdivision (LHb) [28,29].
Morphological and electrophysiological studies have indicated
that the habenula receives and modulates noxious inputs [30,31].
For example, electrical stimulation or microinjection of morphine
into the habenula induces analgesia in the formalin test [32,33]
and an injection of formalin into the hindpaw of rats is reported to
elicit the expression of Fos-protein within the LHb [34]. Formalin
injections are also associated with increased Fos-protein expression
in stress-sensitive regions, including the paraventricular thalamus
(PVT) [22].
Clearly, early life events are important in shaping the
nociceptive circuitry. We have previously demonstrated that
neonatal LPS exposure exerts developmentally regulated changes
in formalin-induced behaviours, corticosterone levels, and dorsal
horn neuronal properties with pronounced changes observed
particularly at PND 22 [10]. In the present study, we aim to
determine the supra-spinal changes associated with the neonatal
immune challenge in PND 22 rats. Specifically, whether the
increased flinching responses observed in preadolescent rats
treated with LPS as neonates is associated with altered neuronal
activity within specific subregions of the PAG, an essential
substrate for opioid-induced analgesia [35,36]. Our hypothesis is
that exposure to LPS during the first postnatal week, when the
descending inhibitory systems are still functionally immature [16],
will alter the neuronal activity within the PAG and subsequently
alter the behavioural responses to formalin injection at PND 22.
Materials and Methods
Animals and Ethics Statement
Five experimentally naı¨ve female Wistar rats were obtained
from the University of Newcastle Animal House and allowed one
week acclimatisation, after which two males were introduced to
their cages. The males were removed after two weeks and dams
were housed individually in custom designed polycarbonate-
perspex home boxes (43.5 cm628 cm612.5 cm; Mascot Wire
Works, Sydney, Australia). Mating occurred at the University of
Newcastle Psychology vivarium and resulted in a total of 68
offspring, from which a subset of males (n = 13) was selected for
use in this study. A maximum of three pups per litter were assigned
to each group and for each experimental condition; animals were
distributed as evenly as possible from all litters used per treatment
to avoid potential litter effects. Until their allocated testing day,
rats were maintained in a temperature (2161uC) and humidity
(60%) controlled environment, under a 12 h/12 h light-dark cycle
(light on 06:00 h) with food (Rat and Mouse Pellets, Glen Forest,
Western Australia) and water available ad libitum. All experiments
were carried out in accordance with the National Health and
Medical Research Council Australian Code of Practice for the
care and use of animals for scientific practice. All procedures were
reviewed and approved by the University of Newcastle Ethics
committee (Ethics approval no. A-2010-127).
Neonatal Endotoxin Exposure
At PND 3 and 5 (birth considered as PND 1), pups were briefly
removed from their home cages, weighed and administered
intraperitoneally (i.p) with either LPS (from Salmonella enterica,
serotype enteritidis; Sigma-Aldrich, USA, dissolved in 20 ml sterile
pyrogen-free saline, 0.05 mg/kg) or an equivalent volume of sterile
saline (Livingstone International, Australia). All injections were
made between 9:00 am and 10:00 am. This model has been
previously used in our [37,38] and other laboratories [12,39] with
the dosage and timing having been demonstrated to induce a rapid
sustained febrile response, but no mortality.
Formalin Testing Procedure
Unlike traditional tests of nociception such as the tail flick and
hot plate tests which investigate acute pain, the formalin test is a
widely accepted model of persistent pain and more closely
resembles clinical cases of chronic pain [40]. Injection of formalin
into the hindpaw of rodents produces a characteristic biphasic
response of flinching and licking of the injected paw, with an early
phase (0–5 min) and a late phase lasting up to 90 min [41,42].
The formalin solution was prepared using Formaldehyde
(36.5%–38%; Biolab Ltd, Victoria, Australia) and preservative-
free saline (Sodium chloride Injection BP 0.9%, Pfizer, Australia).
At PND 22, all rats (neonatal saline: n = 6; neonatal LPS: n = 7)
underwent a subcutaneous injection of 1.1% formalin into the
plantar surface of the left hindpaw using a 31 G needle (10 ml).
The choice of formalin concentration range, volume and site of
injection was based on our previous work [42]. Rats were tested in
transparent Plexiglas boxes (30 cm (w)630 cm (l)630 cm (h)). A
mirror was mounted 45u beneath the floor to allow for an
unobstructed view of the paws and a camera was mounted to
record the behavioural responses from the reflection of the mirror.
Behavioural recording was done on a DVD recorder for one-hour
post formalin injection. Flinching and licking were scored based on
the method of Wheeler-Aceto and Cowan [43] and was carried
out by a trained experimenter blind to treatment condition of each
animal. The one-hour of behavioural recording was divided into
an early phase (the first 5 min) and a late phase (10 to 60 min)
during which the frequency of flinching (paw lifting or shaking) as
well as the duration licking the injected paw (in seconds) was
scored. PND 22 rats were tested at room temperature and at this
age, an acclimation period was not required as during this period
of development rats are still unable to recognize and interact with
the environment [44].
No saline-injected rats were included in this study since it has
been previously shown that rats subjected to a subcutaneous
injection of saline into the plantar surface of the hindpaw do not
display flinching or licking behaviour when tested during the first
three postnatal weeks and adulthood [45–47]. Prior spinal cord
Fos studies showed that infant rats receiving less than 20 ml saline
demonstrated no Fos labelling [48].
Perfusion, Brain Collection and Immunohistochemistry
Rats were deeply anaesthetized with an overdose of Lethabarb
(2 mg/kg i.p; Virbac, Pty. Ltd, Milperra, Australia) one and a half
hours following the formalin test. This time point was selected as
Fos-protein expression has been shown to peak at 1.5–2 hrs
following stimuli exposure [49,50]. Animals were transcardially
perfused with 150 mls of normal saline followed by 500 mls of 4%
paraformaldehyde (pH 9.5). Brains were removed, postfixed and
cryoprotected (24 hours, at 4uC) in the same fixative solution with
the addition of 15% sucrose. Brains were then stored in 15%
sucrose in 0.1 M phosphate buffer (pH 7.4 at 4uC). Serial coronal
sections of the rostral forebrain (40 mm) and caudal midbrain
(50 mm) were cut on a freezing microtome (Leica SM 2000R,
Leica Biosystems, Germany). A 1-in-4 series of brain sections from
the habenula (lateral and medial sections, bregma 22.16 to 2
3.60) and the PVT (bregma22.16 to23.60), and a 1-in-5 series of
the rostral (bregma 27.64), medial (bregma 28.0) and caudal
(bregma 28.3) PAG [51] were processed for immunohistochem-
ical detection of Fos-protein (72 h, 1:10000, rabbit polyclonal,
Santa Cruz Biotechnology, CA, USA) as described previously
[52,53]. Sections were then incubated in a secondary antibody
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biotinylated anti-rabbit (2 hours, 1:300 donkey anti-rabbit, Jackson
ImmunoResearch, PA, USA). Finally, sections were incubated in
diaminobenzodine (DAB) in 2% filtered nickel sulphate (NiSO4)
for 15 minutes before glucose oxidase (0.2 mL per mL of solution)
was added to visualise Fos-protein.
Fos-positive cell counts were determined by creating boundaries
around each brain structure. The VLPAG boundary did not
include the raphe nuclei. After selecting the region of interest, a
thresholding procedure was used for Fos expression. Fos counts
were quantified using MetaMorph Imaging System Software
(Version 7.5; MDS Analytical Technologies) under a 10x
microscopic objective (Olympus CX40).
Statistical Analysis
Data analysis was carried out using the Statistical Package for
the Social Sciences for Windows, version 20 (SPSS). A Linear
Mixed Model (LMM) was applied to analyse the behavioural, and
Fos-protein immunohistochemistry data (For more details about
LMM, see [42]). For behavioural responses, the area under the
curve (AUC) which was the sum of flinching or licking responses
from 10 to 60 min was calculated and analysis was carried out
using an ANCOVA with litter size as a covariate variable. Post-
hoc analyses (two-tailed) were carried out using Least Significant
Differences (LSD) tests. An alpha value of 0.05 was adopted for all
tests.
Results
Formalin Responses in Preadolescent Rats: Neonatal
Immune Challenge Alters Formalin-induced Nociception
in both the Early and Late Phase
The characteristic biphasic response was observed in preado-
lescent rats in both treatment groups in flinching and licking of the
injected paw. However, neonatal LPS-treated rats displayed
higher flinching during the early and late phase. LMM analysis
of flinching responses revealed a significant two way interaction of
Time and Treatment [F(7,11) = 8.02, p,.01] implying that
neonatal LPS treatment altered the inflammatory pain response
in preadolescent rats. Pairwise comparisons revealed that LPS
treated rats displayed significantly higher flinching responses
during the late phase at 20 min post formalin injection when
compared to their matched saline control group (p,.05;
Figure 1A). Pairwise comparisons also revealed that during the
early phase (first 5 min), LPS-treated rats had significantly higher
flinching responses compared to saline (p,.05). Moreover, analysis
of the AUC during the late phase revealed that LPS treated rats
had significantly higher flinching responses compared to the saline
group [F(1,11) = 5.25, p,.05; Figure 1A]. LMM analysis revealed
no significant differences in licking responses between neonatally
saline or LPS-treated rats in both the early and late phase of the
formalin test (Figure 1B).
Formalin-induced Fos-protein Expression in Brain Areas
Involved in Stress and Analgesia
Fos-protein expression in the PAG was examined in the three
main subdivisions (DPAG; LPAG; and VLPAG) and across three
rostrocaudal axes (rostral, medial, and caudal). In the DPAG,
LMM analysis revealed a significant effect of treatment
[F(1,25) = 7.52; p,.05] within the DPAG at the rostral level.
Pairwise comparisons revealed that neonatal saline-treated rats
displayed significantly higher numbers of Fos-positive cells
compared to neonatal LPS-treated rats following formalin
injection (p,.01). No significant differences were found in the
medial and caudal part of the PAG (Figure 2E, Table 1).
No significant differences were found in terms of Fos-positive
nuclei on the ipsilateral versus contralateral side of either the
LPAG or the VLPAG, and therefore these data were combined. In
the LPAG, LMM analysis revealed a strong trend towards
decreased Fos-positive neurons in LPS-treated rats, however this
did not reach significance (p = .062; Figure 2F). In contrast, there
was a significant main effect of treatment on the induction of Fos-
protein in both the rostral and caudal VLPAG [F(1,34) = 5.71; p,
.05; F(1,34) = 8.39; p,.01, respectively]. Pairwise comparisons
Figure 1. Neonatal LPS exposure enhances formalin-induced nociception in preadolescent rats. Time course of flinching (A) and licking
(B) responses following an injection of 1.1% formalin (mean 6 SEM). AUC: the Area Under the Curve.
doi:10.1371/journal.pone.0098382.g001
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revealed that neonatal saline-treated rats exhibited significantly
higher Fos-positive neurons compared to LPS animals in the
rostral (p = .05) and caudal (p,.05) VLPAG (Figure 2G, Table 1).
Bilateral Fos-protein labelling was observed in the LHb and
medial Habenula (MHb). No significant differences were observed
in Fos-like immunoreactivity in the ipsilateral versus contralateral
Table 1. Fos expression in the periaqueductal grey (PAG).
Treatment Axis DPAG LPAG VLPAG
Sal/formalin Rostral 52.0614.5 35.0612.2 106.0633.1
Medial 22.868.3 40.8614.9 64.0619.7
Caudal 16.5610.2 36.269.1 102.2646.3
LPS/formalin Rostral 11.662.4 15.664.6 38.0613.6
Medial 18.366.0 22.067.2 36.8610.6
Caudal 6.663.1 29.264.9 23.269.3
Note: Data are presented as mean number of Fos-positive cells per section 6 SEM.
doi:10.1371/journal.pone.0098382.t001
Figure 2. Fos immunoreactivity in the midbrain periaqueductal grey (PAG) following a neonatal immune challenge and subsequent
inflammatory pain. Representative examples illustrate the distribution of Fos-positive nuclei in the dorsal and ventrolateral PAG (DPAG, VLPAG,
respectively) at the rostral (A & B) and caudal (C & D) axes following formalin injection in preadolescent rats. (E) Quantification of Fos-positive nuclei in
DPAG between neonatal saline and LPS-treated rats. (F) Quantification of Fos-positive nuclei in lateral PAG (LPAG). (G) Quantification of Fos-positive
nuclei in VLPAG. Data are presented as mean 6 SEM. *p,.05; **p,.01. Scale bar = 100 mm.
doi:10.1371/journal.pone.0098382.g002
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sides of formalin injection, and therefore data from both sides were
combined. LMM analysis revealed a significant main effect of
subregion [F(1,18) = 46.17; p,.001] implying that the LHb and
MHb showed different pattern of Fos activation. Pairwise
comparisons indicated that regardless of the neonatal challenge,
significantly greater levels of Fos-protein expression were observed
in the LHb compared to the MHb following formalin injection
(p,.001; Figure 3A & 3B).
The PVT is known to express Fos following formalin injection
into the hindpaw in rats [22]. There was a trend towards increased
levels of Fos immunoreactivity in the PVT in neonatal saline-
treated animals compared to LPS-treated animals, however this
failed to reach significance (p = .175) (Table 2).
Discussion
The current study demonstrates that exposure to an immune
challenge during the neonatal period is accompanied by enhanced
behavioural responses to formalin in preadolescent rats. We
observed increased susceptibility of preadolescent rats to formalin-
induced flinching but not licking behaviours in LPS-treated rats.
This LPS-induced hyperalgesia was associated with distinct
recruitment of supra-spinal structures as indicated by significantly
attenuated Fos-protein expression in the rostral DPAG as well as
rostral and caudal axes of the VLPAG.
Neonatal Exposure to LPS Alters Flinching but not
Licking Responses in Preadolescent Rats
The nociceptive system undergoes fine-tuning and maturation
during the first postnatal weeks of development [54]. While C-
fibers are present within the spinal cord prenatally, they become
functional and respond to noxious stimuli only during the second
postnatal week. For instance, the ability of C-fibers to produce
neurogenic oedema appears only at PND 11–14 [55]. Moreover,
application of mustard oil, a specific C-fibers irritant, to the
hindlimb skin does not induce Fos-protein expression in the spinal
cord until the second week of development [56]. These findings
suggest that the nociceptive circuitry is highly malleable during
early postnatal life. Therefore, exposure to a physiological insult
such as LPS during the first weeks of postnatal life, where the
neurocircuitry underlying nociception undergoes significant plas-
ticity, is likely to interfere with the normal developmental
trajectory of the nociceptive system, leading to altered behavioural
and neuronal responses following exposure to noxious stimuli later
in development.
The current study demonstrated that neonatal LPS exposure
produced increased flinching but not licking during both phases of
the formalin test. These findings are in accordance with our
previous work whereby neonatal LPS exposure was able to alter
flinching but not licking patterns in preadolescent rats [10].
Flinching and licking are mediated by distinct neural pathways.
Whilst the spontaneous rhythmicity of flinching behaviour suggests
this behaviour is spinally modulated, the complex movements
involved in licking behaviour suggest it engages supraspinal
modulation. Indeed, intrathecal injection of Lidocaine into the
lumbar spinal cord prior to formalin injection abolishes flinching
response during the late phase [57]. However, transection of the
spinal cord at the mid-thoracic level has been shown to have no
effect on formalin-induced flinching [57], but completely abolishes
formalin-induced licking [43]. The findings reported in these
animal studies suggest that the generation of flinching and licking
behaviours result from the activation of distinct neural pathways.
Exposure to an immune challenge is thus able to alter either the
spinal or supraspinal circuitry leading to alteration in the intensity
and profile of the biphasic formalin response later in development.
Together, the current findings suggest that neonatal exposure to
LPS enhances the sensitivity of preadolescent rats to inflammatory
noxious stimuli (i.e. hyperalgesia). This is in accordance with a
recent study demonstrating that rats challenged with LPS at PND
14 displayed enhanced mechanical and thermal nociception when
tested in adulthood (8 to 12 weeks old) [58]. In this study a
subsequent exposure to LPS in adulthood failed to alter the
behavioural responses to mechanical and thermal stimuli [58].
These data suggest that a single immune challenge is sufficient to
disrupt nociception later in life. The current findings add to the
literature by demonstrating that a neonatal immune challenge can
Figure 3. Fos immunoreactivity in the habenula following a
neonatal immune challenge and subsequent inflammatory
pain. (A) Representative examples illustrate the distribution of Fos-
positive nuclei in the lateral and medial habenula (LHb & MHb,
respectively). (B) Quantification of Fos-positive nuclei in LHb and MHb
in neonatal saline (white bar) and LPS-treated rats (grey bar) after
formalin injection in preadolescent rats. 3V: third ventricle. ***p,.001.
Scale bar = 100 mm for the 10x microscopic objective and 200 mm for
20x microscopic objective.
doi:10.1371/journal.pone.0098382.g003
Table 2. Fos expression in the paraventricular nucleus of the thalamus (PVT) and the lateral and medial habenula (LHb & MHb).
Treatment PVT LHb MHb
Sal/formalin 22.166.0 43.668.3 1.960.4
LPS/formalin 14.362.1 42.768.6 1.260.3
Note: Data are presented as mean number of Fos-positive cells per section 6 SEM.
doi:10.1371/journal.pone.0098382.t002
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also alter inflammatory nociception as indicated by enhanced
formalin-induced flinching in preadolescent rats.
Neonatal LPS Exposure Results in Distinct Recruitment of
Supra-spinal Structures Involved in Analgesia following
Formalin Injection
Electrical or chemical stimulation of the PAG produces
profound analgesia in rats [18,20,25,36,59,60]. The PAG is
organized into longitudinal columns [24,61], with a dorsal, lateral,
and ventrolateral column. The current study demonstrates that in
response to a neonatal immune challenge and subsequent
inflammatory pain at PND 22, preadolescent rats exhibited
distinct patterns of Fos-protein expression within these columns.
At PND 22, following formalin injection, LPS-challenged rats
exhibited significantly attenuated levels of Fos-protein in both
rostral DPAG and rostral and caudal VLPAG compared to saline-
challenged rats. Interestingly, although there was a strong trend
towards reduced Fos-protein expression in the LPAG in LPS-
treated rats, this did not reach statistical significance, possibly due
to the lack of power in our analyses. These findings are in
agreement with recent observations showing significantly in-
creased Fos immunolabelling in the caudal part of the DPAG
and VLPAG following formalin injection in PND 14 rats [22].
Electrical or opiate stimulation of the DPAG and VLPAG has
been previously reported to induce analgesia in infant and adult
rats [62–64]. For instance, injection of the m-opiate agonist,
DAMGO into both ventral and dorsal PAG was associated with
enhanced paw withdrawal latency to a noxious thermal stimulus
(47uC water) in 3, 10, and 14 day-old rats [63]. Since stimulation
of both the VLPAG and DPAG mediates analgesia [25,65], the
reduction in Fos-labelling within the DPAG and VLPAG of LPS-
challenged rats is likely associated with the observed hyperalgesia
in these animals following the formalin injection.
In addition to the PAG, the LHb has also been demonstrated to
play an important role in mediating analgesia in the formalin test
[32,33]. Further, increased neuronal depolarization was observed
in the LHb in response to noxious peripheral stimulation [30].
Importantly, these effects appear to be specific to the LHb, as adult
rats injected with formalin have been previously shown to display
increased Fos labelling in the LHb but not the MHb [34].
Moreover, electrical stimulation of the LHb but not the MHb in
freely moving rats has been shown to evoke naloxone-reversible
analgesia in the tail flick test [66]. Together, these findings suggest
that compared to the MHb, neurons in the LHb respond
specifically to noxious stimulations. This is consistent with our
findings where formalin injection into the hindpaw of preadoles-
cent rats was associated with increased Fos-protein labelling in the
LHb as compared to MHb. However, in the current study, the
intensity of Fos-protein expression was not affected by neonatal
immune challenge. It is however possible that formalin injection
resulted in maximal Fos-protein expression in LHb across both
groups, thereby preventing the identification of a treatment effect.
Morphological studies have revealed the existence of afferent
and efferent connections between the habenula and the PAG
[28,34,67,68]. The habenula constitutes an important relay in the
descending pathway to the PAG to subserve antinociception
[69,70]. Administration of morphine into the habenula of a rabbit
produced a marked increase in the withdrawal reflex latency to
radiant heat [69]. This antinociception was dose-dependently
attenuated by intra-PAG administration of the opiate antagonist
naloxone [69]. Furthermore, the antinociception induced by intra-
habenula injection of morphine, was attenuated by muscimol (a
GABA receptor agonist) injected into the PAG [69]. These data
suggest that morphine can act on the habenula to activate a neural
descending pathway projecting to the PAG to mediate analgesia.
This pathway seems to implicate the release of endogenous opioid
peptides and GABA. Of particular interest, stimulation of the LHb
was reported to inhibit the unit discharges of nociceptive-specific
neurons within the PAG [71]. The findings reported in these
animal studies are consistent with a recent human study that
revealed, using fMRI technique, an interrelated activity of
habenula and PAG following noxious thermal stimulation [70].
Since no significant differences were observed in the LHb, it is
possible that an alternate structure innervated the PAG to mediate
the decreased behavioural responses to formalin observed in
control animals. Another possibility is that the analgesia observed
in control animals could be attributed to PAG activation alone.
Further research is required to examine these possibilities.
Conclusion
The ability to perceive and respond to noxious stimuli is critical
for survival. Equally important is the recruitment of supra-spinal
structures involved in analgesia to reduce the suffering associated
with pain. The current study importantly demonstrates that
neonatal exposure to LPS results in decreased neuronal activation
within the PAG following exposure to a noxious inflammatory
stimulus in preadolescence. We have also demonstrated that
neonatal exposure to LPS produces altered behavioural responses
to formalin injection in preadolescent rats. These findings
highlight the importance of neonatal immune challenge in
programming behavioural and supra-spinal responses to inflam-
matory pain later in development.
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